Anthropic CEO Names the Main Grievance Against AI Companies

cryptonews.ruPublished on 2026-08-17Last updated on 2026-08-17

Abstract

Anthropic CEO Dario Amodei addressed the core criticism against AI companies: their failure to deliver on grand promises of global benefit. This, he argues, has fueled a "fundamental crisis of trust" in technology. Amodei stated that marketing and hype, such as claims that AI will cure cancer, have become clichés and are perceived as deceptive. The solution, he said, is to deliver tangible results. While acknowledging he focuses equally on AI's risks and benefits, Amodei accepted the industry's responsibility, stating the most valid criticism is that it hasn't yet shown major positive impact. He emphasized Anthropic's commitment to advancing work in biology and medicine. In the related debate, investor Gavin Baker urged more positive promotion of AI, while AI researcher Yann LeCun argued for widely available, open AI systems, contrasting with Anthropic's caution towards powerful open-source models. Others, like an OpenAI specialist, noted that trust depends not only on technological achievements but also on product accessibility, pricing, and transparency.

The most justified grievance against AI companies is that they have yet to fulfill their grand promises of bringing tangible benefits to the world. This statement was made by Anthropic CEO Dario Amodei, linking society's negative attitude towards the technology to a "fundamental crisis of trust."

1/2 Thanks Gavin for an especially thoughtful exchange. I don't usually spend much time on social media but I wanted to engage here because it really brings out the heart of an important conversation.

First, on regulation, I think that “either concentrate it in the hands of a... https://t.co/2W6vWJAE8Y

— Dario Amodei (@DarioAmodei) August 15, 2026

The post was a response to a message from investor Gavin Baker, who accused the Anthropic CEO of excessively negative rhetoric and urged him to speak more actively about the benefits of artificial intelligence. According to Amodei, public perception can no longer be changed with marketing: instead of promises that AI will help cure cancer, the industry will have to show real results.

Debate on the Reasons for Distrust in AI

In Baker's opinion, Amodei "lost the debate" on AI regulation and should become a more positive advocate for his own industry, as he is "about to become the CEO of one of the most important public companies in the world." The Anthropic CEO responded with a series of posts on X. He noted that he usually doesn't spend much time on social media but decided to join the discussion because it touches on "the heart of an important conversation."

According to Amodei, he gives roughly equal attention to the risks and benefits of the technology. As a positive example, he recalled the essay Machines of Loving Grace, dedicated to the potential impact of powerful AI on medicine, economics, and quality of life.

However, the Anthropic CEO agreed with the very existence of a negative attitude towards the technology:

"I think at the core is a fundamental crisis of trust. Ordinary people do not trust companies, governments, or the technology industry and always suspect that we are inventing some new way to deceive them."

In his opinion, the reasons for this distrust have been forming for decades, and AI has merely become its latest manifestation.

"That's Entirely on Us"

At the same time, Amodei acknowledged the responsibility of the AI industry itself. He named the most fair criticism of companies like Anthropic as the fact that they have yet to fulfill their major promises of bringing tangible benefits to the world.

"That's entirely on us. I think that's what we should be criticized for, not for all these things related to messaging and marketing," wrote the Anthropic CEO.

In his opinion, the situation cannot be fixed with a new advertising campaign: claims that AI will be able to cure cancer have already become clichés and are perceived by many as deceptive.

"Only one thing will work — actually curing cancer," emphasized Amodei.

The startup's head added that the company intends to intensify its work in biology and medicine. According to him, "incredible results" are possible in the coming years. However, Amodei did not specify what exactly he meant.

Bet on Openness

Not everyone agreed with Amodei's approach. AI researcher Yann LeCun responded that for about ten years, he has believed the only correct direction is the development of technologies that will be widely accessible, shared, and open.

For about 10 years now, I have argued that the *only* way forward is for AI technology to be widely available, shared, and open.
Like the printing press and the Internet, AI amplifies human intelligence and efficiency by improving access to knowledge.
To empower individuals,...

— Yann LeCun (@ylecun) August 16, 2026

According to him, artificial intelligence, like the printing press and the internet, amplifies human capabilities by expanding access to knowledge.

"We need diverse AIs for the same reason we need a diverse press," wrote LeCun.

He also quoted Mark Zuckerberg's position, according to which the very idea of AI so dangerous that the only safe option becomes extreme concentration of power seems problematic.

This approach diverges from Anthropic's policy regarding the most powerful systems. The company does not advocate for a complete ban on open-weight models as a class but believes it is necessary to enhance safety requirements as their capabilities grow.

Another objection was raised by OpenAI GTM specialist Angel Brodin, as reported by Business Insider. She drew attention to the pharmaceutical industry: real achievements in medicine do not prevent it from remaining among the industries with low public trust.

In her opinion, the attitude towards AI companies will also depend not only on technological results but also on product accessibility, pricing, lobbying, transparency, and the distribution of economic benefits.

Previously, ForkLog compiled the most interesting projects showing how distributed databases and artificial intelligence help solve practical tasks far beyond the financial sector.

Trending Cryptos

Related Questions

QWhat, according to Anthropic CEO Dario Amodei, is the most justified criticism of AI companies?

AThe most justified criticism is that AI companies have not yet fulfilled their grand promises to bring significant benefit to the world, leading to a 'fundamental crisis of trust'.

QWhy did investor Gavin Baker criticize Dario Amodei, and what was Amodei's counterpoint regarding changing public perception?

AGavin Baker criticized Amodei for being overly negative in his rhetoric and urged him to talk more actively about the benefits of AI. Amodei countered that perception cannot be changed with marketing or more promises; the industry must instead show tangible, real-world results.

QWhat example did AI researcher Yann LeCun use to argue for open and widely accessible AI, and how does this contrast with some of Anthropic's views?

AYann LeCun compared AI to the printing press and the Internet, stating it amplifies human capabilities by improving access to knowledge and must be widely available and open. This contrasts with Anthropic's policy that, while not advocating a complete ban on open-weight models, believes safety requirements must be strengthened as the capabilities of powerful systems grow.

QWhat point did OpenAI's Angel Brodin make by referencing the pharmaceutical industry in the context of public trust in AI?

AAngel Brodin noted that despite real medical achievements, the pharmaceutical industry remains one with low public trust. She argued that public trust in AI companies will similarly depend not only on technological results, but also on factors like product accessibility, pricing, lobbying, transparency, and the distribution of economic benefits.

QWhat specific area did Dario Amodei say Anthropic intends to strengthen its work in, and what did he claim about the potential timeline for results?

ADario Amodei stated that Anthropic intends to strengthen its work in biology and medicine. He claimed that 'incredible results' in these fields are possible in the coming years, though he did not provide specific details.

Related Reads

Ilya Delivers, Huang Jen-Hsun Bets 50 Billion on SSI, First Model Suspected to Launch This Week

Ilya Sutskever's Safe Superintelligence (SSI) lab, backed by a rumored $5 billion investment from NVIDIA granting exclusive access to next-gen systems, may release its first groundbreaking model as early as this week. Industry insiders are hinting at a major breakthrough from a non-major player, with some claiming AI will be "utterly transformed." The model is speculated to fundamentally differ from current large language models like ChatGPT. Instead of relying on massive, static pre-training and ever-larger context windows, SSI's approach reportedly centers on **Test-Time Training (TTT)**. This would allow the model to **update its own internal weights in real-time** as it processes information, effectively "learning on the fly" and internalizing new knowledge like a human, rather than just referencing it from a large prompt. This aligns with Ilya Sutskever's long-stated vision of moving beyond the "pre-training" and "scaling" era. He envisions superintelligence not as a monolithic, pre-loaded database, but as an adaptive, "infinitely curious 15-year-old genius" capable of continual learning through interaction. SSI's strategy has been focused solely on this goal of "safe superintelligence" through efficient continual learning and alignment, explaining its prior silence. If successful, this model could disrupt the entire AI industry, challenging the current reliance on vast compute resources for training and the business models built around context windows. It suggests that core technological leaps, not just financial scale, remain decisive in the AI race.

marsbit41m ago

Ilya Delivers, Huang Jen-Hsun Bets 50 Billion on SSI, First Model Suspected to Launch This Week

marsbit41m ago

Demand Test: Bitcoin Whales Earn Record $1.2 Billion, Ethereum Holders Return to Profitability

In just three days after Bitcoin's price recovery, new Bitcoin whales have realized over $1.2 billion in profit, marking the largest profit-taking event for this cohort on record according to CryptoQuant. The peak occurred on August 20 with roughly $614 million, setting a daily record. Analysts note this selling pressure began after Bitcoin rose above the realized price of short-term whales, which was around $68,900. With Bitcoin trading near $77,700 on August 23, these whales were sitting on an average profit of about 12.8%. The market recovery allowed investors who were previously at breakeven or at a loss to lock in gains. CryptoQuant described the situation as a key test for Bitcoin demand; sustained prices above whale cost-basis with normalized profit-taking could signal strong new demand, while continued selling pressure could turn the rally into a mere break-even exit. Simultaneously, large Ethereum holders have also returned to an unrealized profit zone following its rally, as noted by CryptoQuant analyst Darkfost. Current profit levels, however, remain relatively low and are not seen as creating significant selling pressure. The Unrealized Profit/Loss Ratio for different whale cohorts stands at 0.075 (for 1k-10k ETH holders), 0.16 (10k-100k ETH), and 0.38 (over 100k ETH). This marks a significant improvement from June, when these whales were in substantial unrealized loss, with Ethereum having risen over 65% since then. The increased profitability is viewed as a positive sentiment signal for the Ethereum market.

cryptonews.ru53m ago

Demand Test: Bitcoin Whales Earn Record $1.2 Billion, Ethereum Holders Return to Profitability

cryptonews.ru53m ago

Kinetiq Team Announces Elysium L2 Network for Hyperliquid

On August 24, the liquid staking protocol Kinetiq announced Elysium, a new L2 network for the Hyperliquid ecosystem. It aims to increase HyperEVM's throughput and simplify the launch of spot markets, tokens, and DeFi applications. Elysium will use $HYPE for gas fees and plans direct integration with HyperCore's trading engine, giving apps access to its liquidity and orderbook data. Technical details and partners will be revealed later, with a launch date set for "soon." A primary reason for Elysium's development is to overcome HyperEVM's limitations, such as low throughput and rising fees during high load. Kinetiq claims the L2 will start with significantly higher block production and transaction speeds, later aiming to approach HyperCore's performance. This targets applications needing frequent state updates like high-frequency spot trading and AMMs, and will provide them deeper access to HyperCore orderbook data. The network also proposes to streamline the process of launching new assets within Hyperliquid, allowing a token to progress from AMM liquidity to HyperCore's spot orderbook and eventually to perp markets via HIP-3 in a unified flow. Regarding revenue, Kinetiq's model allocates 50% of sequencer fees to buy back and burn $KNTQ, 25% to developers using Elysium's block space, and 25% to the Kinetiq treasury. Elysium marks Kinetiq's expansion beyond its core liquid staking product, kHYPE.

cryptonews.ru54m ago

Kinetiq Team Announces Elysium L2 Network for Hyperliquid

cryptonews.ru54m ago

Trading

Spot

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of AI (AI) are presented below.

活动图片